Copyright
©The Author(s) 2005.
World J Gastroenterol. Aug 14, 2005; 11(30): 4753-4757
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4753
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4753
Figure 1 Electrophoresis of HLA-DRB1*03,*07,*09,*12,*15 alleles.
M: pUC19 DNA/MspI (HpaII) marker 23; 1: DRB1*0701/0702, 232 bp; 2: DRB1*0901, 236 bp; 3: DRB1*1201/1202, 248 bp; 4: DRB1*1501/1502, 197 bp; 5: DRB1*0301/ 0302, 151 bp.
Figure 2 Electrophoresis of HBV genotypes.
M: pUC19 DNA/MspI (HpaII) marker 23; lane 1: genotype B (281 bp); lane 2: genotype C (122 bp); lane 3: genotype B+C; lane 4: negative control.
- Citation: Chu RH, Ma LX, Wang G, Shao LH. Influence of HLA-DRB1 alleles and HBV genotypes on interferon-α therapy for chronic hepatitis B. World J Gastroenterol 2005; 11(30): 4753-4757
- URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4753.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4753